跳至主要内容
临床试验/NCT05145491
NCT05145491招募中不适用

Randomized Trial Comparing Immediate Versus Deferred Surgery for Symptomatic Epiretinal Membranes

Jaeb Center for Health Research78 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2022年2月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
78
主要终点
Mean change in visual acuity letter score from baseline to 36 months

研究概览

简要总结

Vitrectomy to remove an epiretinal membrane (ERM) is one of the most common procedures performed by retinal surgeons. Patients who present with significant macular changes on optical coherence tomography (OCT) but relatively good vision are often advised to defer surgery until vision declines to 20/40 or worse. However, it is unknown if delaying surgery, which allows the foveal architecture to remain compromised and potentially to deteriorate, results in worse visual acuity outcomes than if surgery is performed earlier. In addition, there is a need to better understand predictors of outcomes when surgery is performed and predictors of progression when surgery is deferred. Finally, one of the most common presenting symptoms from an ERM is distortion or metamorphopsia. There are several objective measures of metamorphopsia but none have ever been employed to evaluate ERMs in a randomized clinical trial (RCT) and their usefulness is unknown. The purposes of this study are to better understand the optimal timing of surgery to produce the best visual result, to better understand predictors of outcomes in those who undergo surgery and predictors of progression in those whose are observed, and to better characterize and evaluate the usefulness of metamorphopsia and reading speed measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 45 years
  • E-ETDRS visual acuity 20/40 or better (≥69 letters)
  • o ERM must be thought to be the primary cause of vision loss
  • ERM meeting the following criteria, according to the investigator
  • ERM is not secondary to another condition
  • Symptoms of visual loss and/or distortion (in the opinion of the investigator, the ERM is contributing to the participant's symptoms); either new or worsening in the past 24 months
  • Epiretinal membrane involving or altering the central 3 mm of the macula on OCT
  • Distortion within the central subfield due to ERM on OCT
  • Immediate vitrectomy not required (investigator and participant are willing to wait at least 4 weeks to see if vision remains stable without having to proceed to vitrectomy)
  • No known medical problems that will be a contraindication to surgery

排除标准

  • History of retinal vascular disease
  • History of vitreous hemorrhage if vitreous hemorrhage is thought to have caused the ERM
  • o History of vitreous hemorrhage is permitted provided the vitreous hemorrhage did not cause the ERM in the investigator's opinion
  • History of inflammatory disease unless mild and completely resolved at least one year prior to randomization
  • History of diabetic macular edema (DME), retinal vein occlusion (RVO), or uveitis (except mild uveitis that resolved >1 year prior to randomization)
  • Prior intraocular surgery (except uncomplicated cataract extraction)
  • Cataract extraction within prior 3 months
  • Laser or cryosurgical retinopexy within one month of randomization
  • Pneumatic retinopexy within one year of randomization
  • Current untreated retinal tear or detachment
  • o A previously treated retinal tear with up to one disc diameter radius of subretinal fluid is permitted
  • Macular hole
  • Degenerative lamellar macular hole
  • o ERM foveoschisis ("tractional" lamellar hole) is permitted
  • Vitreomacular traction within 1,500 microns of foveal center
  • Central serous chorioretinopathy
  • Nonproliferative diabetic retinopathy or worse (DR severity >20)

研究组 & 干预措施

Immediate Vitrectomy

Active Comparator

干预措施: Immediate Vitrectomy (Procedure)

Deferred Vitrectomy

Other

干预措施: Deferred Vitrectomy (Procedure)

结局指标

主要结局

Mean change in visual acuity letter score from baseline to 36 months

时间窗: Baseline to 36 months

Visual acuity is measured as a continuous integer letter score from 0 to 100, with higher numbers indicating better visual acuity. A letter score of 85 is approximately 20/20 and a letter score of 70 is approximately 20/40, the legal unrestricted driving limit in most states. A 5-letter change for an individual is approximately equal to a 1-line change on a vision chart.

次要结局

未报告次要终点

研究者

发起方
Jaeb Center for Health Research
申办方类型
Other
责任方
Sponsor

研究点 (78)

Loading locations...

相似试验

Randomized Trial Comparing Immediate vs. Deferred... | 临床试验